These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 18258852

  • 1. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.
    Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F.
    Am J Pathol; 2008 Mar; 172(3):786-98. PubMed ID: 18258852
    [Abstract] [Full Text] [Related]

  • 2. Transgenic mouse models for Alzheimer's disease: the role of GSK-3B in combined amyloid and tau-pathology.
    Muyllaert D, Terwel D, Borghgraef P, Devijver H, Dewachter I, Van Leuven F.
    Rev Neurol (Paris); 2006 Oct; 162(10):903-7. PubMed ID: 17028556
    [Abstract] [Full Text] [Related]

  • 3. Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy.
    Maurin H, Chong SA, Kraev I, Davies H, Kremer A, Seymour CM, Lechat B, Jaworski T, Borghgraef P, Devijver H, Callewaert G, Stewart MG, Van Leuven F.
    PLoS One; 2014 Oct; 9(2):e87605. PubMed ID: 24498342
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L×GSK3β mice by delaying brainstem tauopathy.
    Crespo-Biel N, Theunis C, Borghgraef P, Lechat B, Devijver H, Maurin H, Van Leuven F.
    Neurobiol Dis; 2014 Jul; 67():119-32. PubMed ID: 24704314
    [Abstract] [Full Text] [Related]

  • 5. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M.
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model.
    Jimenez S, Torres M, Vizuete M, Sanchez-Varo R, Sanchez-Mejias E, Trujillo-Estrada L, Carmona-Cuenca I, Caballero C, Ruano D, Gutierrez A, Vitorica J.
    J Biol Chem; 2011 May 27; 286(21):18414-25. PubMed ID: 21460223
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β.
    Maurin H, Lechat B, Borghgraef P, Devijver H, Jaworski T, Van Leuven F.
    Eur J Neurosci; 2014 Jul 27; 40(2):2442-53. PubMed ID: 24754737
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice.
    Sun J, Zhang X, Wang C, Teng Z, Li Y.
    Am J Chin Med; 2017 Jul 27; 45(8):1667-1682. PubMed ID: 29132216
    [Abstract] [Full Text] [Related]

  • 17. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C, Borghgraef P, Matarazzo V, Gielis L, Lajard AM, Voituron N, Gestreau C, Dutschmann M, Van Leuven F, Hilaire G.
    Respir Physiol Neurobiol; 2011 Sep 15; 178(2):290-303. PubMed ID: 21763469
    [Abstract] [Full Text] [Related]

  • 18. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
    Haggerty T, Credle J, Rodriguez O, Wills J, Oaks AW, Masliah E, Sidhu A.
    Eur J Neurosci; 2011 May 15; 33(9):1598-610. PubMed ID: 21453448
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
    Engel T, Goñi-Oliver P, Lucas JJ, Avila J, Hernández F.
    J Neurochem; 2006 Dec 15; 99(6):1445-55. PubMed ID: 17059563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.